相关实验视频
Updated: Jan 29, 2026

05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
18.4K
整合酶链转移抑制剂ACC01717的抗HIV-1活性
Meng-Di Ma1,2, Rong-Hua Luo1, Chun-Yan Li1,3
1State Key Laboratory of Genetic Evolution & Animal Models, Key Laboratory of Bioactive Peptides of Yunnan Province, KIZ-CUHK Joint Laboratory of Bioresources and Molecular Research in Common Diseases, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650223, China.
Viruses
|January 28, 2026
概括
ACC017是一种新的HIV-1整合酶链转移抑制剂 (INSTI),具有强大的抗病毒活性. 它对抗耐药性HIV菌株有效,并表现出良好的耐药性概况,使其成为有前途的治疗候选者.
科学领域:
- 病毒学 病毒学
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
背景情况:
- 艾滋病毒-1整合酶链转移抑制剂 (INSTIs) 在抗逆转录病毒疗法中至关重要.
- 耐药突变的出现需要新的治疗药物.
研究的目的:
- 介绍ACC017作为一个新的INSTI候选人.
- 评估ACC017.7的抗病毒活性和耐药性概况.
主要方法:
- 在体外抗病毒活性测定对HIV-1菌株.
- 行动研究的机制,以评估整合酶抑制.
- 在体外耐药性选择研究.
主要成果:
- ACC017对HIV-1IIIB (EC50=0.59nM) 和耐药菌株 (EC50范围:0.119.12nM) 显示出强烈的活性.
- 抑制HIV-1整合酶酶以IC50=9.19nM的速度进行抑制.
- 抗性选择产生了D232N和R263K突变,避免了常见的抗性突变.
结论:
- ACC017表现出强大的抗病毒活性和有利的耐药性.
- 与其他抗逆转录病毒药物的协同相互作用表明了治疗潜力.
- ACC017是艾滋病毒治疗进一步发展的有希望的候选人.
相关概念视频
Lagging Strand Synthesis
61.3K
During replication, the complementary strands in double-stranded DNA are synthesized at different rates. Replication first begins on the leading strand. Replication starts later, occurs more slowly, and proceeds discontinuously on the lagging strand.
There are several major differences between synthesis of the leading strand and synthesis of the lagging strand. 1) Leading strand synthesis happens in the direction of replication fork opening, whereas lagging strand synthesis happens in the...
There are several major differences between synthesis of the leading strand and synthesis of the lagging strand. 1) Leading strand synthesis happens in the direction of replication fork opening, whereas lagging strand synthesis happens in the...
61.3K
Lagging Strand Synthesis
16.6K
16.6K
Eukaryotic Transcription Inhibitors
11.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
Fixing Double-strand Breaks
14.6K
The double-stranded structure of DNA has two major advantages. First, it serves as a safe repository of genetic information where one strand serves as the back-up in case the other strand is damaged. Second, the double-helical structure can be wrapped around proteins called histones to form nucleosomes, which can then be tightly wound to form chromosomes. This way, DNA chains up to 2 inches long can be contained within microscopic structures in a cell. A double-stranded break not only damages...
14.6K
Fixing Double-strand Breaks
4.4K
4.4K
Transfer RNA Synthesis
13.3K
One of the unique features of tRNA is the presence of modified bases. In some tRNAs, modified bases account for nearly 20% of the total bases in the molecule. Altogether, these unusual bases protect the tRNA from enzymatic degradation by RNases.
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
13.3K

